» Articles » PMID: 31909181

and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide

Overview
Publisher Cell Press
Date 2020 Jan 8
PMID 31909181
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Although the physicochemical properties of antimicrobial peptides (AMPs) and anticancer peptides (ACPs) are very similar, it remains unclear which specific parameter(s) of ACPs confer the major anticancer activity. By answering how to construct a short AMP/ACP that could easily be synthesized in the most cost effective way plus conferring a maximum anticancer effect is a very important scientific breakthrough in the development of protein/peptide drugs. In this study, an 18-amino-acids antimicrobial peptide, AcrAP1 (named AP1-Z1), was used as a template. Bioinformatics algorithms were then performed to design its six mutants (AP1-Z3a, AP1-Z3b, AP1-Z5a, AP1-Z5b, AP1-Z7, and AP1-Z9). After a series of experiments plus intensive computational analysis, the data demonstrated that AP1-Z5a and AP1-Z5b induced both apoptosis and anti-angiogenic effects to achieve the maximum anticancer activity. Specifically, the most effective mutant, AP1-Z5b, exhibited high selectivity for the charged membrane in molecular dynamics simulations. These findings clearly demonstrated that both charge and hydrophobicity play an important role and are necessary to reach an optimum equilibrium for optimizing the anticancer activity of AMPs. Overall, the present study provides a very crucial theoretical basis and important scientific evidence on the key physicochemical parameters of ACP drugs development.

Citing Articles

Investigation of anticancer potential of a novel bioactive molecule from Trichosporon asahii VITSTB1 in breast cancer cell lines: an in vitro study.

Stany B, Mishra S, Tharani P, Sarkar A, Mandal A, Rao K Med Oncol. 2024; 42(1):19.

PMID: 39609299 DOI: 10.1007/s12032-024-02569-1.


Discovery, development and optimisation of a novel frog antimicrobial peptide with combined mode of action against drug-resistant bacteria.

Wang J, Hu J, Pu W, Chen X, Ma C, Jiang Y Comput Struct Biotechnol J. 2024; 23:3391-3406.

PMID: 39345903 PMC: 11437748. DOI: 10.1016/j.csbj.2024.09.006.


Bombinin-BO1 induces hepatocellular carcinoma cell-cycle arrest and apoptosis via the HSP90A-Cdc37-CDK1 axis.

Wang X, Tang P, Gong Y, Yao H, Liang M, Qu H iScience. 2024; 27(8):110382.

PMID: 39108730 PMC: 11301096. DOI: 10.1016/j.isci.2024.110382.


A Lipid-Sensitive Spider Peptide Toxin Exhibits Selective Anti-Leukemia Efficacy through Multimodal Mechanisms.

Zhang P, Luo W, Zhang Z, Lv M, Sang L, Wen Y Adv Sci (Weinh). 2024; 11(32):e2404937.

PMID: 38962935 PMC: 11348133. DOI: 10.1002/advs.202404937.


Peptidome Profiling of Urine and Assessment of Its Antimicrobial Activity against Mastitis-Causing Pathogens.

Kumar R, Tyagi N, Nagpal A, Kaushik J, Mohanty A, Kumar S Antibiotics (Basel). 2024; 13(4).

PMID: 38666975 PMC: 11047597. DOI: 10.3390/antibiotics13040299.


References
1.
Wang Y, Li D, Shi H, Wen Y, Yang L, Xu N . Intratumoral expression of mature human neutrophil peptide-1 mediates antitumor immunity in mice. Clin Cancer Res. 2009; 15(22):6901-11. DOI: 10.1158/1078-0432.CCR-09-0484. View

2.
Xu H, Chen C, Hu J, Zhou P, Zeng P, Cao C . Dual modes of antitumor action of an amphiphilic peptide A(9)K. Biomaterials. 2013; 34(11):2731-7. DOI: 10.1016/j.biomaterials.2012.12.039. View

3.
Vedham V, Divi R, Starks V, Verma M . Multiple infections and cancer: implications in epidemiology. Technol Cancer Res Treat. 2013; 13(2):177-94. DOI: 10.7785/tcrt.2012.500366. View

4.
Hoskin D, Ramamoorthy A . Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta. 2007; 1778(2):357-75. PMC: 2238813. DOI: 10.1016/j.bbamem.2007.11.008. View

5.
Wang G . Human antimicrobial peptides and proteins. Pharmaceuticals (Basel). 2014; 7(5):545-94. PMC: 4035769. DOI: 10.3390/ph7050545. View